Molecular response of leukemia HL-60 cells to genistein treatment, a proteomics study

Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/33168

Title:	Molecular response of leukemia HL-60 cells to genistein treatment, a proteomics study
Authors:	Zhang, D. Koay, E.S.-C. Tai, Y.-C. Wong, C.-H.S. Chen, C.-S. Tai, L.-K.
Keywords:	Cell cycle arrest Genistein Leukemia HL-60 Proteomics Tyrosine kinase
Issue Date:	2007
Citation:	Zhang, D., Koay, E.S.-C., Tai, Y.-C., Wong, C.-H.S., Chen, C.-S., Tai, L.-K. (2007). Molecular response of leukemia HL-60 cells to genistein treatment, a proteomics study. Leukemia Research 31 (1) : 75-82. ScholarBank@NUS Repository.
Abstract:	Genistein (GEN) is a natural protein tyrosine kinase inhibitor. We analyzed the molecular response of HL-60 cells to GEN treatment by gel-based proteomics approach. Fourteen differentially expressed proteins which are functionally involved in metabolism, cell signaling, RNA processing, cell proliferation and motility, and chaperones were identified. Both the dose- and time-dependent up-regulation of Hsp70 protein 8 and heterogeneous nuclear ribonucleoprotein (hnRNP) H1, and the down-regulation of Rab14, hnRNP C and stathmin-1 by GEN were verified by immunoblot analysis. Our novel findings provide insightful clues to the potential therapeutic targets for leukemia treatment in diverse tyrosine kinase-dependent cellular pathways. © 2006 Elsevier Ltd. All rights reserved.
Source Title:	Leukemia Research
URI:	http://scholarbank.nus.edu.sg/handle/10635/33168
ISSN:	01452126
Appears in Collections:	Staff Publications

There are no files associated with this item.

Check